BRC Therapeutics (BRC), a pharmaceutical company developing proprietary therapeutics for neurological and inflammatory diseases, tod ...

CHS is a condition marked by abdominal pain, nausea, and persistent vomiting linked to prolonged heavy cannabis use. This ...

THC and CBD can interfere with how some meds work, making them less effective A study published in April 2020 found the number of Americans age 65 and older who smoke marijuana or enjoy edibles ...

Neurodegenerative diseases such as Parkinson’s, Alzheimer's and others are increasing worldwide as the population ages. According to Alzheimer's Disease International, more than 50 million persons ...

DeFloria Advancing Charlotte's Web Legacy as Pioneer in Cannabinoid Health, with Phase 2 Clinical Trials for Autism Botanical Drug LOUISVILLE, Colo. and WASHINGTON, Dec. 19, 2025 /CNW/ - DeFloria Inc.

PHILADELPHIA, July 21, 2022 /PRNewswire/ -- Zelira Therapeutics Ltd (ASX: ZLD, OTC-QB: ZLDAF), a global leader in the research, development and commercialization of clinically validated cannabinoid ...

Cannabis has long been used as a form of self-medication, but what happens when use of that drug requires medication itself? Anebulo Pharmaceuticals hopes to be the first to answer that, as the ...

In recent years, the pharmaceutical landscape has witnessed a seismic shift as cannabinoids transition from niche alternatives to mainstream medical solutions. The days of skepticism surrounding ...

Aclara Research, a cannabis and wellness trends consulting firm, released the results of a year-long study examining cannabis and CBD usage habits among consumers. The company partnered with Ipsos, a ...

Penn State researchers have developed a new app that could help pharmacists and other health care providers improve patient safety by modeling how medical and recreational marijuana may interact with ...